IN2012DN01661A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01661A IN2012DN01661A IN1661DEN2012A IN2012DN01661A IN 2012DN01661 A IN2012DN01661 A IN 2012DN01661A IN 1661DEN2012 A IN1661DEN2012 A IN 1661DEN2012A IN 2012DN01661 A IN2012DN01661 A IN 2012DN01661A
- Authority
- IN
- India
- Prior art keywords
- disclosed
- compounds
- intended
- kits
- abstract
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102000011420 Phospholipase D Human genes 0.000 abstract 1
- 108090000553 Phospholipase D Proteins 0.000 abstract 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22849209P | 2009-07-24 | 2009-07-24 | |
| PCT/US2010/043045 WO2011011680A1 (en) | 2009-07-24 | 2010-07-23 | Isoform selective phospholipase d inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN01661A true IN2012DN01661A (enExample) | 2015-06-05 |
Family
ID=43499428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1661DEN2012 IN2012DN01661A (enExample) | 2009-07-24 | 2010-07-23 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9127005B2 (enExample) |
| EP (1) | EP2456307B1 (enExample) |
| JP (1) | JP2013500260A (enExample) |
| KR (1) | KR20120090034A (enExample) |
| CN (1) | CN102573474A (enExample) |
| AU (1) | AU2010275526A1 (enExample) |
| BR (1) | BR112012001586A2 (enExample) |
| CA (1) | CA2768940C (enExample) |
| IL (1) | IL217720A0 (enExample) |
| IN (1) | IN2012DN01661A (enExample) |
| MX (1) | MX2012001064A (enExample) |
| RU (1) | RU2012106657A (enExample) |
| SG (1) | SG178102A1 (enExample) |
| WO (1) | WO2011011680A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9453017B2 (en) | 2011-09-30 | 2016-09-27 | Vanderbilt University | Antiviral therapies with phospholipase D inhibitors |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2012DN01661A (enExample) | 2009-07-24 | 2015-06-05 | Univ Vanderbilt | |
| WO2014093557A1 (en) * | 2012-12-11 | 2014-06-19 | Vanderbilt University | Methods and compositions comprising akt inhibitors and/or phospholipase d inhibitors |
| AU2013359311A1 (en) * | 2012-12-11 | 2015-07-23 | Vanderbilt University | Methods and compositions of treating HIV infection |
| CN114778844A (zh) * | 2022-03-07 | 2022-07-22 | 天津市肿瘤医院（天津医科大学肿瘤医院） | Pld1作为评估肿瘤患者对于化疗药物敏感性的分子标志物的用途 |
| AR129618A1 (es) * | 2022-06-16 | 2024-09-11 | Japan Tobacco Inc | Compuesto de dihidrooxadiazinona y su uso farmacéutico |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1281502B1 (it) | 1995-06-13 | 1998-02-18 | Sardinian Antiviral Research C | Impiego di un inibitore non nucleosidico della trascrittasi inversa in associazione con inibitori nucleosidici per il trattamento della |
| US6187559B1 (en) | 1997-08-28 | 2001-02-13 | Novartis Ag | Phospholipase D gene |
| WO2001089449A2 (en) | 2000-05-25 | 2001-11-29 | Ben Williger | Phospholipase d effectors for therapy and screening |
| US6482829B2 (en) * | 2000-06-08 | 2002-11-19 | Hoffmann-La Roche Inc. | Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor |
| US20060172363A1 (en) | 2002-09-18 | 2006-08-03 | Postech Foundation | Peptide complexes containing phospholipase d |
| KR20070106690A (ko) * | 2004-12-27 | 2007-11-05 | 아스트라제네카 아베 | 피라졸론 화합물 및 대사성 글루타메이트 수용체길항제로서 그들의 용도 |
| WO2006107451A2 (en) | 2005-02-23 | 2006-10-12 | Univ Emory | Honokiol derivatives for the treatment of proliferative disorders |
| DE602007009221D1 (de) * | 2006-05-18 | 2010-10-28 | Hoffmann La Roche | Thiazolopyramidin/pyridinharnstoffderivate als antagonisten am adenosin-a2b-rezeptor |
| US20100009970A1 (en) | 2008-03-19 | 2010-01-14 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
| WO2010037081A1 (en) | 2008-09-29 | 2010-04-01 | Palatin Technologies, Inc. | Melanocortin receptor-specific spiro-piperidine compounds |
| CA2756141A1 (en) | 2009-03-31 | 2010-10-07 | Sanofi-Aventis Deutschland Gmbh | Drug delivery device body |
| EP2435563A4 (en) | 2009-05-29 | 2013-10-02 | Univ Columbia | MODULATION OF PHOSPHOLIPASE D FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES |
| IN2012DN01661A (enExample) | 2009-07-24 | 2015-06-05 | Univ Vanderbilt | |
| WO2011019498A1 (en) | 2009-07-27 | 2011-02-17 | The Trustees Of Princeton University | Inhibition of glycerol-3-phosphate acyltransferase (gpat) and associated enzymes for treatment of viral infections |
| CA2850597A1 (en) | 2011-09-30 | 2013-04-04 | Vanderbilt University | Antiviral therapies with phospholipase d inhibitors |
| WO2014093557A1 (en) | 2012-12-11 | 2014-06-19 | Vanderbilt University | Methods and compositions comprising akt inhibitors and/or phospholipase d inhibitors |
| AU2013359311A1 (en) | 2012-12-11 | 2015-07-23 | Vanderbilt University | Methods and compositions of treating HIV infection |
-
2010
- 2010-07-23 IN IN1661DEN2012 patent/IN2012DN01661A/en unknown
- 2010-07-23 CN CN2010800423044A patent/CN102573474A/zh active Pending
- 2010-07-23 CA CA2768940A patent/CA2768940C/en not_active Expired - Fee Related
- 2010-07-23 KR KR1020127004698A patent/KR20120090034A/ko not_active Withdrawn
- 2010-07-23 AU AU2010275526A patent/AU2010275526A1/en not_active Abandoned
- 2010-07-23 WO PCT/US2010/043045 patent/WO2011011680A1/en not_active Ceased
- 2010-07-23 US US13/386,397 patent/US9127005B2/en not_active Expired - Fee Related
- 2010-07-23 EP EP10802947.1A patent/EP2456307B1/en not_active Not-in-force
- 2010-07-23 BR BRBR112012001586-9A patent/BR112012001586A2/pt not_active IP Right Cessation
- 2010-07-23 RU RU2012106657/04A patent/RU2012106657A/ru not_active Application Discontinuation
- 2010-07-23 MX MX2012001064A patent/MX2012001064A/es not_active Application Discontinuation
- 2010-07-23 JP JP2012521826A patent/JP2013500260A/ja active Pending
- 2010-07-23 SG SG2012005252A patent/SG178102A1/en unknown
-
2012
- 2012-01-24 IL IL217720A patent/IL217720A0/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9453017B2 (en) | 2011-09-30 | 2016-09-27 | Vanderbilt University | Antiviral therapies with phospholipase D inhibitors |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2768940A1 (en) | 2011-01-27 |
| JP2013500260A (ja) | 2013-01-07 |
| CA2768940C (en) | 2018-03-13 |
| US20120214832A1 (en) | 2012-08-23 |
| SG178102A1 (en) | 2012-03-29 |
| BR112012001586A2 (pt) | 2015-09-01 |
| WO2011011680A1 (en) | 2011-01-27 |
| CN102573474A (zh) | 2012-07-11 |
| US9127005B2 (en) | 2015-09-08 |
| EP2456307B1 (en) | 2016-11-02 |
| AU2010275526A1 (en) | 2012-03-15 |
| EP2456307A4 (en) | 2013-01-16 |
| RU2012106657A (ru) | 2013-08-27 |
| MX2012001064A (es) | 2012-07-17 |
| KR20120090034A (ko) | 2012-08-16 |
| IL217720A0 (en) | 2012-03-29 |
| EP2456307A1 (en) | 2012-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY150542A (en) | Cmet inhibitors | |
| PT2470546E (pt) | Compostos de hexa-hidrooxazinopteridina para serem utilizados como inibidores de mtor | |
| MY150596A (en) | Hsp90 inhibitors | |
| EA201190227A1 (ru) | Оксазолзамещенные индазолы в качестве ингибиторов pi3-киназ | |
| WO2010008847A3 (en) | Pi3k/m tor inhibitors | |
| TR201203989T1 (tr) | Ksantin oksidaz inhibitörleri olarak etkin olan yeni bileşikler, bunları hazırlamaya yönelik yöntem ve bunları içeren farmasötik bileşim. | |
| MX2012006805A (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa. | |
| WO2013003298A3 (en) | Inhibitors of pde10 | |
| NZ704662A (en) | Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid | |
| BRPI1009333B8 (pt) | compostos inibidores de beta-secretase, seus usos, bem como composição farmacêutica | |
| MX336381B (es) | Boronatos como inhibidores de arginasa. | |
| WO2013067349A9 (en) | Novel chemistry used in biosensors | |
| EA201490912A1 (ru) | Производные [1,2,3]триазоло[4,5-d]пиримидина в качестве агонистов каннабиноидного рецептора 2 | |
| ECSP12011581A (es) | Inhibidores de bace | |
| MX2009003834A (es) | Derivados de pirrolidina como inhibidores de iap. | |
| BR112013031405A2 (pt) | piridopirazinas substituídas como novos inibidores de syk | |
| CY1112829T1 (el) | Νεα μεθοδος συνθεσης για την αγομελατινη | |
| EA201270302A1 (ru) | Безводные формы производных пиридина | |
| PH12013500554A1 (en) | Process for preparing pan-cdk inhibitors of the formula (i) and intermediates in the preparation | |
| EA201391481A1 (ru) | Аналоги эпоксиэйкозатриеновой кислоты и способы их получения и использования | |
| MX2012007341A (es) | Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso. | |
| IN2012DN01661A (enExample) | ||
| EA200900090A1 (ru) | Бензиламины, способ их получения и их применение в качестве противовоспалительных средств | |
| PH12015501175A1 (en) | Substituted pyridopyrazines as syk inhibitors | |
| MX391837B (es) | Composiciones depuradoras de oxigeno. |